OXU-001

suprachoroidal sustained-release ocular implant · Oxular Limited

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for OXU-001, covering 2025-09-03 to 2025-09-03. Get the full timeline:

Most recent: Clinical Trial Update: Suprachoroidal Sustained-Release OXU-001 Compared to Intravitreal Ozurdex® in the Treatment of Diabetic Macular Edema [Phase 2]

See pricing